Timothy Coughlin - Apr 26, 2022 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
Stock symbol
LIFE
Transactions as of
Apr 26, 2022
Transactions value $
$0
Form type
4
Date filed
4/28/2022, 07:42 PM
Previous filing
Jun 4, 2021
Next filing
May 12, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Restricted Stock Units Award $0 +6K $0.00 6K Apr 26, 2022 Common Stock 6K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.